• LAST PRICE
    22.1300
  • TODAY'S CHANGE (%)
    Trending Down-0.2900 (-1.2935%)
  • Bid / Lots
    18.0000/ 1
  • Ask / Lots
    24.6400/ 5
  • Open / Previous Close
    22.4900 / 22.4200
  • Day Range
    Low 21.7500
    High 22.7000
  • 52 Week Range
    Low 16.4900
    High 30.2100
  • Volume
    525,546
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 22.42
TimeVolumeXNCR
09:32 ET269022.68
09:38 ET10022.465
09:39 ET45022.47
09:41 ET10022.31
09:43 ET50222.32
09:45 ET40022.33
09:48 ET10022.24
09:52 ET30022.24
09:54 ET30022.13
09:56 ET100022.12
09:57 ET50022.04
09:59 ET60021.955
10:01 ET30022.06
10:03 ET116422.06
10:08 ET73621.95
10:10 ET20021.85
10:12 ET30021.75
10:14 ET77221.87
10:15 ET10021.87
10:21 ET10021.825
10:24 ET20021.82
10:26 ET80021.86
10:28 ET20021.855
10:32 ET10021.83
10:33 ET10021.83
10:35 ET285922.03
10:42 ET40022.06
10:46 ET20022.06
10:48 ET108522.045
10:50 ET100022.085
10:51 ET50022.1
10:53 ET10022.12
10:55 ET70022.15
10:57 ET10022.15
11:00 ET117622.16
11:02 ET10022.155
11:04 ET40022.12
11:06 ET41522.15
11:08 ET69222.17
11:09 ET10022.18
11:11 ET121022.135
11:13 ET70022.15
11:15 ET34322.1301
11:18 ET60022.19
11:20 ET10022.21
11:24 ET70022.23
11:26 ET30022.26
11:27 ET30022.3
11:31 ET50022.305
11:33 ET20022.3
11:36 ET10022.33
11:38 ET50022.3
11:44 ET24822.325
11:45 ET329022.31
11:47 ET40022.32
11:49 ET40022.36
11:51 ET1680522.56
11:54 ET70022.605
11:56 ET22622.54
12:00 ET50022.56
12:02 ET110022.6
12:03 ET417022.66
12:05 ET130022.64
12:07 ET170022.575
12:09 ET160022.57
12:12 ET20022.57
12:14 ET460422.57
12:16 ET60022.5993
12:18 ET20022.5994
12:20 ET300022.57
12:21 ET249022.53
12:23 ET70022.53
12:25 ET352722.53
12:27 ET114122.58
12:30 ET110022.6
12:32 ET60022.53
12:34 ET488122.5
12:36 ET1005522.41
12:38 ET169922.44
12:39 ET334222.35
12:41 ET505222.3093
12:43 ET20022.285
12:45 ET30022.3
12:48 ET50022.29
12:52 ET10022.34
12:54 ET799922.23
12:56 ET112222.305
12:57 ET20022.34
12:59 ET10022.33
01:01 ET105922.27
01:03 ET20022.255
01:06 ET62822.27
01:10 ET20022.225
01:12 ET70022.305
01:14 ET10022.305
01:17 ET242122.24
01:19 ET80322.31
01:21 ET63222.31
01:24 ET51922.32
01:26 ET30022.35
01:28 ET45422.34
01:30 ET45322.34
01:32 ET95022.31
01:33 ET50022.31
01:35 ET100022.29
01:37 ET40022.3396
01:39 ET40022.36
01:42 ET170422.36
01:46 ET90022.35
01:48 ET260022.3
01:50 ET92522.26
01:51 ET398822.11
01:55 ET40022.13
01:57 ET30022.15
02:02 ET170022.21
02:06 ET40022.19
02:09 ET30022.24
02:11 ET10022.24
02:13 ET10022.23
02:15 ET40022.23
02:18 ET152922.22
02:20 ET30022.16
02:22 ET10022.13
02:24 ET10022.14
02:26 ET10022.14
02:27 ET10022.14
02:29 ET60022.19
02:31 ET74422.19
02:33 ET60022.24
02:36 ET42822.19
02:40 ET20022.155
02:42 ET20022.15
02:44 ET80022.175
02:45 ET70022.21
02:47 ET71522.2177
02:49 ET70022.255
02:51 ET40022.23
02:58 ET226122.195
03:05 ET20022.22
03:07 ET40022.26
03:09 ET20022.28
03:12 ET20022.29
03:14 ET184022.27
03:16 ET10022.25
03:18 ET75622.23
03:20 ET82322.216
03:21 ET100022.23
03:23 ET60022.2
03:25 ET20022.19
03:27 ET50022.18
03:30 ET80022.15
03:32 ET49622.125
03:34 ET60022.13
03:36 ET165622.11
03:38 ET110022.09
03:41 ET40222.08
03:43 ET247222.035
03:45 ET65222.02
03:48 ET30022.01
03:50 ET218821.96
03:52 ET2653422.1
03:54 ET280022.19
03:56 ET3597822.12
03:57 ET347822.15
03:59 ET12920122.13
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesXNCR
Xencor Inc
1.4B
-10.5x
---
United StatesDCPH
Deciphera Pharmaceuticals Inc
1.2B
-6.9x
---
United StatesMIRM
Mirum Pharmaceuticals Inc
1.2B
-6.2x
---
United StatesMNKD
MannKind Corp
1.3B
-97.6x
---
United StatesPRTA
Prothena Corporation PLC
1.4B
-8.8x
---
United StatesARCT
Arcturus Therapeutics Holdings Inc
884.4M
-29.2x
---
As of 2024-03-29

Company Information

Xencor, Inc. is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases. More than 20 candidates engineered with its XmAb technology are in clinical development, and three XmAb medicines are marketed by partners. Its XmAb engineering technology enables small changes to a protein structure that result in new mechanisms of therapeutic action. Its wholly owned development candidates include Vudalimab, XmAb819, XmAb808, and XmAb541. Candidates co-developed with partners include Plamotamab. Candidates advanced by partners include Xaluritamig (AMG 509), ASP2138, JNJ-9401, JNJ-1493, and Novartis XmAb undisclosed antibody candidate. Its cytokine drug candidates in clinical development consist of fbalropendekin alfa (XmAb306/RG6323), XmAb564, and XmAb662. Its other clinical-stage drug candidates consist of Obexelimab, AIMab7195 (XmAb7195), and Xpro1595. Vudalimab is a bispecific antibody that targets PD-1 and CTLA-4.

Contact Information

Headquarters
465 N. HALSTEAD ST., SUITE 200PASADENA, CA, United States 91107
Phone
626-305-5900
Fax
626-305-0350

Executives

President, Chief Executive Officer, Founder and Director
Bassil Dahiyat
Chief Financial Officer, Senior Vice President
John Kuch
Executive Vice President - Research, Chief Scientific Officer
John Desjarlais
Executive Vice President, Chief Development Officer
Nancy Valente
Senior Vice President, General Counsel, Company Secretary
Celia Eckert

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.4B
Revenue (TTM)
$168.3M
Shares Outstanding
61.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.76
EPS
$-2.10
Book Value
$10.96
P/E Ratio
-10.5x
Price/Sales (TTM)
8.1
Price/Cash Flow (TTM)
---
Operating Margin
-82.36%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.